Abstract
INTRODUCTION
It has been confirmed that Yinchenhao Decoction has the efficacy of "clearing away heat and promoting diuresis, promoting blood circulation and removing blood stasis" and has the significant pharmacological effect to anti fatty liver from clinical practice and basic research. 1 At the same time, we were using mathematical model of "uniform design method" to optimize the dosage ratio of Yinchenhao Decoction, and the result showed that "3 g capillaris with 1.5 g Gardenia" was the effective traditional Chinese medicine and optimal dosage ratio in the Yinchenhao Decoction for anti NAFLD. 2 It is manifested that "uniform design" can be a valid means to optimize the dosage ratio of compound Traditional Chinese Medicine (TCM). 3 With the continuous development of TCM analysis technology, the theory that the effective components of TCM is the material base of TCM compound to exert pharmacologic effects has been widely accepted. 4 Studies have shown that chlorogenic acid is the main effective component in capillaries, has function to antibacterial and cholagogic, to scaveng free radicals and antioxidant pharmacological; 5 while gardenia glycosides is the main effective component in gardenia, with pharmacologic effects of analgesic and anti-inflammatory, hepatoprotective and choleretic. 6 Previous experimental research found that the combination of chlorogenic acid and gardenia glycosides has the similar effect to the compatibility of Herba Artemisiae Scopariae and gardenia which can reduce fat content in HepG2 cells induced by free fatty acid (FFA). It has been concluded that combination of chlorogenic acid and gardenia glycosides is the important material basis for treating fatty liver disease, but the optimal dosage ratio still unclear. This study aimed to investigate the optimal dosage ratio of chlorogenic acid and gardenia glycosides in the treatment of rates with fatty liver disease induced by high-fat feed.
MATERIALS AND METHODS

Animals
Wistar male rats, sanitary degree, 4 weeks, weighing (180 ± 10) g, were purchased from Shanghai Silaike Ex- 
Animals model establishment and treatment
The models were induced with high fat feed (HFD), which consisted of 83.25% basic feed, 10% lard, 1.5% cholesterol, 0.2% sodium deoxycholate, 5% sugar, 0.05% prothio-pyrimidine; the control group was fed with regular diet.
Uniform design "screening" experiment
According to Uniform design, 3 U6 (6 4 ) has been used to arrange the different dose of chlorogenic acid and gardenia glycosides, X1 represent chlorogenic acid and X2 represent gardenia glycosides. For both these two effective components of Chinese herbal medicine, 6 levels were used, from 15 to 90 mg (Table 1 ).
Uniform design "verification" experiment
According to the results of Uniform design "screening" experiment, the group and its dosage were determined for Uniform design "verification" experiment. The 50 rats were randomly divided into 5 groups: control group, the model group, optimal dose matched group, chlorogenic acid group and gardenia glycosides group, 10 in each group. 90 mg chlorogenic acid and 90 mg gardenia glycosides for 1 kg rats once day for the optimal dose matched group, 90 mg chlorogenic acid for 1 kg rats once day for Chlorogenic acid group and 90 mg gardenia glycosides for 1 kg rats once day for the Gardenia glycosides group. The rats in the optimal dose matched group, the chlorogenic acid group and gardenia glycosides group were intragastrically administered the solution (1 mL/100 g body weight) respectively for 4 weeks. Rats in the model group and the control group were given drinking water (1 mL/ 100 g body weight). After the last administration was finished, the rats fasted for 12 h. Then they were weighed and anesthetized with intraperitoneal injec-tion of 2% pentobarbital (3 mL/kg body weight). The abdomen was cut open, and blood was taken from the inferior vena cava and centrifuged at 4 ℃ for 15 min at 3000 r/min. The supernatant was taken and stored at -80 ℃ . The liver was removed and two small pieces in the same location of right lobe of the liver were taken and placed into 10% neutral formaldehyde buffer for fixation. Other liver tissues were further cut into several parts, and kept in centrifuge tubes and stored at -80℃.
Measured variables and methods
Hematoxylin and eosin (HE) staining were used to determine pathological changes of hepatic tissue. After HE staining, the degrees of lipid degeneration of liver cells were observed under a light microscope. Enzyme colorimetric analysis was used for the detection of triglyceride and FFA levels in the liver tissues. Lai's method was used for the detection of serum ALT and AST activity. Liver MDA and SOD activity has been detected with ELISA.
Statistical analyses
All data were analyzed with SPSS 13.0 (SPSS Inc., Chicago, IL, USA). The continuous data were expressed with mean ± standard deviation ( x ± s). One-way analysis of variance was performed to test the differences between the groups. Multiple regression analysis was performed for Uniform design "screening" experiment. P < 0.05 was considered statistically significant.
RESULTS
Uniform design "screening" experiment
As shown in Table 2 , HFD significantly increased triglyceride by 4.2 folds when compared with regular fed rats (P < 0.01). HFD increased FFA compared to the rats in the control group (251 ± 36) vs (82 ± 12) μmol/ g prot (P < 0.01). Compared with the control group (32.4 ± 6.2) and (34.3 ± 7.4) U/L, serum ALT and ·d -1 Gardenia glycosides, all 6 groups were intragastrically administered once a day for 4 weeks from the beginning of the fifth week to the end of eighth week. The control group and model group were intragastrically administered an equal volume of drinking water at the same time. ·d -1 Gardenia glycosides, all 6 groups were intragastrically administered once a day for 4 weeks from the beginning of the fifth week to the end of eighth week. The control group and model group were intragastrically administered an equal volume of drinking water at the same time. The control group was fed with regular diet and the model group induced by high fat feed (HFD), both of control group and model group were intragastrically administered an equal volume of drinking water at the same time. Compared with the control group, a P < 0.01.
AST activity in the model group significantly increased (86.6 ± 20.3) and (89.3 ± 21.4) U/L (P < 0.01). For liver MDA and SOD activity, HFD significantly increased MDA, while decreased SOD activity in model group (P < 0.01). From Table 3 , it can be concluded that the optimal dose matched between the chlorogenic acid and gardenia glycosides. In order to inhibit the HFD on rats, the optimal dose matched was 90 mg chlorogenic acid + 90 mg gardenia glycosides.
Uniform design "verification" experiment
Body weight and liver weight: FD increased body weight compared to the rats in the control group (435 ± 39) vs (332 ± 24) g, and increased liver weight by 2.1 folds compared to control group (17.5 ± 0.8) vs (8.4 ± 0.7) g, and increased fat weight compared to control group (10.5 ± 1.3) vs (6.4 ± 0.5) g. The body weight liver weight and fat weight were significantly lighter in the optimal dose matched group, the chlorogenic acid group and the gardenia glycosides group than those in the model group (P < 0.05, P < 0.01; Table 4) .
Triglyceride and FFA level in liver tissue
HFD significantly increased triglyceride and FFA by 3 and 2.8 folds when compared with normal chow fed rats. The optimal dose matched group, the chlorogenic acid group, and the gardenia glycosides group all significantly reduced the elevated levels of triglyceride and FFA induced by HFD, compared to the model group (Table 5) .
Serum ALT and AST activity in serum
Compared with the control group (24.4 ± 5.6) and (25.8 ± 3.9) U/L, serum ALT and AST activity in the model group significantly increased (72.1 ± 12.6) and (70.4 ± 14.8) U/L (P < 0.01), and compared with the model group, serum ALT, AST activities in the treatment groups significantly decreased (P < 0.05, P < 0.01).
Liver tissue MDA and SOD activity
Compared with the control group, liver MDA activity in the model group significantly increased while SOD activity decreased (P < 0.01); compared with the model group, the treatment group has function to improve the changes (P < 0.05, P < 0.01).
Pathological changes in hepatic tissue
The photomicrographs of the HE stain showed that HFD increased hepatic fat deposit, evidenced by the majority of the hepatocytes of HFD rats distended by fat in comparison to the control group ( Figures 1A,  1B) . The images of HE staining also displayed macrovesicular steatosis for many single large droplets had displaced the nucleus and ballooning degeneration caused conspicuous swelling of the cell and cytoplasmic vacuolation ( Figure 1B ). In the decoction group and the solution group, lipid degeneration and inflammatory response were significantly alleviated compared with the model group. Liver cell volume became smaller, hepatic lobules were clearly delineated, and the fat droplets were reduced ( Figure 1C-1E ).
DISCUSSION
NAFLD is a kind of metabolic stress liver injury, which is closely related to insulin resistance and genetic susceptibility. In recent years, the global epidemiological survey shows that NAFLD is the most common liver disease in the world, and its prevalence in developed countries is 30%, the prevalence of the disease in developing countries is also close to 10% . 8 Modern medicine, however, has not found a specific effective drug for NAFLD. 9 It has confirmed that TCM is one of the major treatment for NAFLD in China. However, it is difficult for TCM to be widely accepted because of the scientific problems "the material basis and effective components of TCM is not clear". 10 With the development of TCM, scholars have generally accepted that the effective components of TCM were important for TCM compound to treat disease. "Uniform design method" is a combination of number theory and multivariate statistical method for experimental design used in the experimental study of multiple factors and levels. At present, the uniform design method has been gradually applied to the study of TCM, it could be used to screen material basis or effective components of TCM compound, [13] [14] [15] and the reliability of its screening has been preliminarily verified. The method is used to simplify the experimental operation, reduce the number of experiments, quantitatively analyze the influence of various factors on the test results, and quantitatively predict the interval estimation of the optimal conditions and the optimization results. Uniform design method has the advantage of fully using multiple factors and levels to analyze components of TCM compound and give quantitative prediction of the condition of compound dosage optimization. Based on our findings, it can be concluded that chlorogenic acid of 90 mg plus gardenia glycosides of 90 mg was the best combination in the treatment of fatty liver disease in rats induced by high-fat diet. Table 5 Comparison of related indexes of all groups ( x ± s) Notes: TG: triglycerides; FFA: free fatty acids; ALT: serum alanine aminotransferase; AST: aspartate aminotransferase; SOD: Oxide dismutase enzyme; MDA: alondialdehyde. The control group was fed with regular diet, the model group induced by high fat feed (HFD) for 8 weeks. Group 1 was the optimal dose matched group, which was induced by HFD and treated with 90 mg·kg ·d -1 chlorogenic acid. Group 1, group 2 and group 3 all were intragastrically administered once a day for 4 weeks from the beginning of the fifth week to the end of eighth week. The control group and model group were intragastrically administered an equal volume of drinking water at the same time.
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